A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults
Wilkie M., Satti I., Minhinnick A., Harris S., Riste M., Ramon RL., Sheehan S., Thomas Z-RM., Wright D., Stockdale L., Hamidi A., O'Shea MK., Dwivedi K., Behrens HM., Davenne T., Morton J., Vermaak S., Lawrie A., Moss P., McShane H.